Jul 2026
Polydatin improves mitochondrial dynamics dysrhythmia by regulating BMAL1 to prevent and treat metabolic dysfunction-associated fatty liver disease.
This is the first study to demonstrate that PD alleviates MAFLD by mediating BMAL1-regulated circadian rhythms of mitochondrial dynamics, positioning PD as a potential therapeutic candidate for MAFLD.
Shu-Jun Wang, Hai-Chao Wang, Guo-Liang Yin et al.
· Journal of Ethnopharmacology · 2 citations